LAKE SUCCESS, N.Y.--(BUSINESS WIRE)--E-Z-EM, Inc. (NASDAQ: EZEM) today announced that the Joint Program Executive Office for Chemical Biological Defense (JPEO-CBD) of the U.S. Department of Defense (DoD) has determined that RSDLTM has satisfied all final configuration testing criteria, and is approved for initial procurements by the individual service branches. The decision, known as Milestone C, clears the way for deployment of RSDL to war-fighters as the DoD’s next generation skin decontaminant for protection against chemical weapons (CW) agents.
